Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 2,313 | 2,938 | 722 | 2,213 | 576 |
| Gross Profit | 2,313 | 2,938 | 722 | 2,213 | 576 |
| Operating Expenses | 13,063 | 21,262 | 19,140 | 9,519 | 3,888 |
| Operating Income | -10,750 | -18,324 | -18,418 | -7,307 | -4,312 |
| Interest Expense | 2 | 2 | 3 | 2 | 0 |
| Other Income | 20 | 74 | 76 | 177 | 216 |
| Pre-tax Income | -10,732 | -18,252 | -18,346 | -7,132 | -4,097 |
| Income Tax | -110 | -482 | -1,579 | -3,246 | N/A |
| Net Income Continuous | -10,622 | -17,770 | -16,767 | -3,886 | -4,097 |
| Net Income | $-10,622 | $-17,770 | $-16,767 | $-3,886 | $-4,097 |
| EPS Basic Total Ops | -0.17 | -0.54 | -0.94 | -0.26 | -0.33 |
| EPS Basic Continuous Ops | -0.18 | -0.54 | -0.94 | -0.26 | -0.34 |
| EPS Diluted Total Ops | -0.17 | -0.54 | -0.94 | -0.26 | -0.33 |
| EPS Diluted Continuous Ops | -0.18 | -0.54 | -0.94 | -0.26 | -0.34 |
| EBITDA(a) | $-10,540 | $-18,251 | $-18,345 | $-7,233 | $-4,242 |